Clinical trial
Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients
NCT02922036
Study timeline
Study start (actual)2018-01-17Date precision: day
Registry last updated2025-07-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failureunresolved
Interventions
WiSE SystemDEVICE
Sponsors & collaborators
EBR Systems, Inc.lead sponsor
Mapped research locations
HoustonTexas, United States2AtlantaGeorgia, United States2LondonUnited Kingdom2Kansas CityKansas, United States2New YorkNew York, United States1ParisFrance1ClevelandOhio, United States1PittsburghPennsylvania, United States1ColumbusOhio, United States1IndianapolisIndiana, United States1MinneapolisMinnesota, United States1JacksonvilleFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02922036 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.